New hope for rare blood vessel disease: drug aims to cut steroids
Disease control
Recruiting now
This study tests a new medicine called NS-229 for people with a rare disease called eosinophilic granulomatosis with polyangiitis (EGPA), which causes inflammation in blood vessels. The goal is to see if NS-229 can help patients achieve remission (no symptoms) while taking a lowe…
Phase: PHASE2 • Sponsor: NS Pharma, Inc. • Aim: Disease control
Last updated May 07, 2026 18:42 UTC